Mammoth Biosciences
Mammoth Biosciences is a biotechnology company focused on developing in vivo gene editing therapeutics and CRISPR-based molecular diagnostics, headquartered in Brisbane, California.
Services
Mammoth Biosciences develops in vivo gene editing therapeutics with the aim of transforming patient lives. The company offers a CRISPR-based detection platform for molecular diagnostics, making cutting-edge precision editing tools available for a range of applications. Both the therapeutic and diagnostic platforms are designed to leverage the power of CRISPR technology to offer innovative solutions in the medical and biotechnology fields.
Products
Mammoth Biosciences focuses on next-generation CRISPR products in both therapeutics and diagnostics. Their therapeutic product line involves the use of CRISPR-based precision editing techniques aimed at treating various diseases. For diagnostics, they offer a CRISPR-based detection platform, providing molecular diagnostic tools that can identify diseases at the genetic level with high accuracy.
History
Headquartered in Brisbane, California, Mammoth Biosciences has made significant strides in the field of gene editing and molecular diagnostics. The company has successfully raised $195 million to continue building on their next-generation CRISPR products. In addition, Mammoth Biosciences collaborates with Regeneron to develop innovative CRISPR-based gene editing solutions aimed at treating multiple diseases.
Collaborations
Mammoth Biosciences collaborates with Regeneron, a partnership focused on pursuing next-generation CRISPR-based gene editing to treat a variety of diseases. This collaboration enhances the potential of CRISPR technology in therapeutic applications by combining Mammoth Biosciences' innovative CRISPR tools with Regeneron's expertise in gene editing.
